All Cosmos Bio-Tech Holding Corp
TWSE:4148
Balance Sheet
Balance Sheet Decomposition
All Cosmos Bio-Tech Holding Corp
All Cosmos Bio-Tech Holding Corp
Balance Sheet
All Cosmos Bio-Tech Holding Corp
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
495
|
563
|
693
|
994
|
592
|
838
|
762
|
740
|
1 342
|
1 459
|
934
|
|
| Cash |
323
|
514
|
612
|
933
|
575
|
717
|
596
|
597
|
967
|
1 080
|
838
|
|
| Cash Equivalents |
171
|
48
|
80
|
60
|
17
|
121
|
166
|
143
|
375
|
379
|
96
|
|
| Short-Term Investments |
30
|
80
|
24
|
23
|
31
|
250
|
89
|
35
|
4
|
112
|
172
|
|
| Total Receivables |
539
|
563
|
384
|
556
|
832
|
363
|
574
|
458
|
728
|
505
|
663
|
|
| Accounts Receivables |
537
|
562
|
382
|
549
|
808
|
330
|
548
|
437
|
699
|
444
|
619
|
|
| Other Receivables |
2
|
2
|
2
|
7
|
24
|
33
|
26
|
21
|
29
|
61
|
44
|
|
| Inventory |
286
|
232
|
235
|
248
|
612
|
296
|
274
|
844
|
1 104
|
591
|
675
|
|
| Other Current Assets |
86
|
79
|
34
|
122
|
66
|
42
|
128
|
225
|
189
|
152
|
217
|
|
| Total Current Assets |
1 435
|
1 517
|
1 370
|
1 943
|
2 134
|
1 789
|
1 827
|
2 302
|
3 367
|
2 818
|
2 661
|
|
| PP&E Net |
647
|
546
|
469
|
476
|
482
|
648
|
606
|
629
|
679
|
803
|
939
|
|
| PP&E Gross |
647
|
546
|
469
|
476
|
482
|
648
|
606
|
629
|
679
|
803
|
939
|
|
| Accumulated Depreciation |
212
|
217
|
229
|
270
|
314
|
345
|
379
|
392
|
456
|
467
|
544
|
|
| Intangible Assets |
2
|
1
|
2
|
2
|
3
|
2
|
1
|
1
|
0
|
9
|
11
|
|
| Goodwill |
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
15
|
15
|
13
|
14
|
30
|
22
|
33
|
|
| Other Long-Term Assets |
277
|
285
|
272
|
267
|
335
|
186
|
167
|
24
|
34
|
20
|
26
|
|
| Other Assets |
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Assets |
2 363
N/A
|
2 350
-1%
|
2 113
-10%
|
2 688
+27%
|
2 975
+11%
|
2 640
-11%
|
2 614
-1%
|
2 970
+14%
|
4 111
+38%
|
3 674
-11%
|
3 671
0%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
109
|
74
|
44
|
40
|
48
|
76
|
66
|
98
|
84
|
131
|
89
|
|
| Accrued Liabilities |
99
|
81
|
71
|
96
|
86
|
46
|
62
|
91
|
106
|
71
|
95
|
|
| Short-Term Debt |
418
|
598
|
282
|
60
|
147
|
9
|
46
|
308
|
394
|
0
|
186
|
|
| Current Portion of Long-Term Debt |
36
|
31
|
28
|
23
|
25
|
20
|
8
|
3
|
12
|
513
|
58
|
|
| Other Current Liabilities |
129
|
22
|
32
|
43
|
85
|
24
|
40
|
62
|
85
|
75
|
51
|
|
| Total Current Liabilities |
791
|
806
|
458
|
263
|
391
|
175
|
221
|
562
|
682
|
790
|
479
|
|
| Long-Term Debt |
154
|
103
|
68
|
46
|
22
|
5
|
1
|
1
|
536
|
30
|
18
|
|
| Deferred Income Tax |
13
|
15
|
29
|
33
|
26
|
32
|
29
|
29
|
31
|
39
|
43
|
|
| Minority Interest |
119
|
191
|
225
|
306
|
364
|
380
|
377
|
388
|
496
|
560
|
615
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Liabilities |
1 076
N/A
|
1 115
+4%
|
780
-30%
|
649
-17%
|
802
+24%
|
594
-26%
|
628
+6%
|
980
+56%
|
1 744
+78%
|
1 419
-19%
|
1 155
-19%
|
|
| Equity | ||||||||||||
| Common Stock |
550
|
565
|
565
|
640
|
640
|
640
|
640
|
640
|
640
|
640
|
640
|
|
| Retained Earnings |
427
|
539
|
726
|
927
|
1 062
|
944
|
962
|
1 096
|
1 367
|
1 344
|
1 410
|
|
| Additional Paid In Capital |
381
|
411
|
411
|
782
|
782
|
782
|
782
|
782
|
782
|
782
|
782
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
71
|
281
|
369
|
310
|
312
|
320
|
398
|
528
|
422
|
512
|
318
|
|
| Total Equity |
1 286
N/A
|
1 235
-4%
|
1 333
+8%
|
2 039
+53%
|
2 172
+7%
|
2 046
-6%
|
1 987
-3%
|
1 990
+0%
|
2 367
+19%
|
2 254
-5%
|
2 515
+12%
|
|
| Total Liabilities & Equity |
2 363
N/A
|
2 350
-1%
|
2 113
-10%
|
2 688
+27%
|
2 975
+11%
|
2 640
-11%
|
2 614
-1%
|
2 970
+14%
|
4 111
+38%
|
3 674
-11%
|
3 671
0%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
58
|
59
|
59
|
67
|
67
|
67
|
67
|
67
|
67
|
67
|
67
|
|